A searchable database of
medically documented cases

About the Project

Spontaneous Regression Of Central Nervous System Posttransplant Lymphoproliferative Disease

Gao, R. 2021Brain tumor

Gao R, Zhang Y, Chen G, Bhekharee AK, Du Z, Chu S. Spontaneous regression of central nervous system posttransplant lymphoproliferative disease: A case report. Medicine (Baltimore). 2021 Feb 12;100(6):e24713. doi: 10.1097/MD.0000000000024713. PMID: 33578612; PMCID: PMC10545224.

View Original Source →

Abstract

Primary central nervous system (CNS) posttransplant lymphoproliferative disease (PTLD) is a very rare entity. Patients may respond to reduction of immunosuppression or other therapies, but the prognosis is still pessimistic. Herein, we report a 40-year-old female with a history of renal transplantation developed brain masses 4 years ago. Although brain biopsy was performed, PTLD was underdiagnosed then. No relevant treatment was administered. However, the lesions resolved spontaneously. After 4 years, new lesion appeared in a different brain region. The history of renal transplantation raised the suspicion of PTLD. Reexamination of previous brain sections confirmed the diagnosis of polymorphic PTLD (P-PTLD). A second biopsy of the new lesion also demonstrated P-PTLD. She was referred to hematology department to receive rituximab. After 4 rounds of treatment, the lesion resolved satisfactorily. This case demonstrates the natural history of primary CNS P-PTLD. Although self-remission and recurrence is possible, aggressive measures should be taken to this condition.

Case Details

Disease Location

Brain

Personal Characteristics

40-year-old female, kidney transplant 17 years ago because of renal failure caused by IGA nephropathy, four years ago, she developed double vision and left-sided weakness. Brain MRI revealed right thalamus and midbrain rim-enhanced lesions. Brain biopsy revealed lymphoid hyperplasia.

Clinical Characteristics

1-month-long progressive right-sided visual field defect. On admission, neurological examinations found a right visual field defect. Positive ebv DNA in csf. Brain MRI demonstrated a rim-enhanced mass in the left temporal lobe. A second brain biopsy was performed. Pathology still suggested p-ptld

Remission Characteristics

Her vision field gradually recovered and brain MRI showed significant improvement

Treatment & Mechanisms

Clinical Treatment

Biopsy 500 mg rituximab injection every month for 4months